Search results for: 'bear gene'

Bearings are crucial for smooth operations of railway vehicles and for the safety of commodities and people being transported. Lowering noise levels and vibrations, high load carrying capacities, and long life are the expectations of bearings in rail. Rail axle bearings are mounted to the wheel axle journal and are a link between the wheel and fram...

This research service offers insight into the global bearings market, key trends, revenue generated by region, and growth areas until 2026, and action items for vendors to enable/retain/improve revenue shares. Though the pandemic disrupted the supply chain, it has made savings more important. This study also takes a quick look at sustainability and...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

25 Jan 2021  |  North America  |  Market Research

Enhanced Wheel Diagnosis Technologies Influencing the North American Wheel Hubs and Bearings Replacement Aftermarket

WDs and Retailers Push Private Labels to Strengthen In-house Brand Name in the Wheel Hubs and Bearings Aftermarket

Infographics

×

Key Issues Addressed

This research service analyzes the volume and value of class 1–3 vehicle hubs and bearings aftermarket in the United States and Canada. It discusses unit shipment, revenue, average price, distribution channel share, and major participants for wheel hub assemblies and for bearing units. The base year for this analysis is 2019, and the forecast perio...

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

Research Scope This study discusses the key growth opportunities for industrial bearings and couplings in both the global and regional market (APAC, the Americas, and EMEA). The key drivers and restrains and their impacts on the global bearings and couplings market are discussed on a global level. The research service also analyzes the total market...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...